Ryan Troup

Ryan Troup is the Editor in Chief of Wealthy VC. Ryan has 15+ years of investing experience. X | Email
Featured

Global Obesity Drug Market to Grow 16x – Top Weight-Loss Stocks to Watch in 2024

With the obesity drug market poised for exponential future growth, here’s the skinny on the top obesity and weight-loss stocks…

Read More »
Biotech

ELEVAI Labs Posts Record Full Year 2023 and Q4 Earnings

The company also reported record Q4 2023 revenue of $698,591, up 403% over the previous quarter. Elevai Labs Inc. (NASDAQ:…

Read More »
Biotech

ELEVAI Labs Launches E-Commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in $19.7B Global Physician Dispensed Cosmeceutical Market

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skin care, is proud to announce the launch of…

Read More »
Top Stories

Nvidia Reports Strong Q4 Earnings, Beats Analysts’ Expectations on Top and Bottom Lines

The company’s Q4 top and bottom line figures represent a massive increase of 265% and 765% over last year’s fourth…

Read More »
Top Stories

The Winners and Losers of Big Tech’s Earnings Season (VIDEO)

Last Updated: Who were the winners and losers of last week’s big tech earnings season? Let’s take a look at…

Read More »
Consumer

ELEVAI Labs Reports Issuance of Patent From U.S. Patent & Trademark Office

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, is pleased to announce that the United States…

Read More »
Top Stories

2 Stocks Correlated to Donald Trump’s Political Success Jump Up to 239% in Past Week (VIDEO)

With Trump winning decisively again tonight in New Hampshire by double digits, investors should keep an eye on these two…

Read More »
Press Releases

ELEVAI Labs Reports Strong Preliminary Unaudited Financials for Fiscal Year 2023

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced certain preliminary, unaudited management-prepared financial results for…

Read More »
Press Releases

ELEVAI Labs Signs Worldwide License Deal for Proprietary Stem Cell Manufacturing Technology

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce it has signed an…

Read More »
Press Releases

ELEVAI Labs to Participate in Upcoming Aesthetic Industry Conferences

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announces participation in three aesthetic industry conferences in…

Read More »
Back to top button